Heart and Vascular Hospital
The Benefits of a WATCHMAN™ Left Atrial Appendage Closure Implant
• After 45 days, most patients were able to stop taking warfarin, and over 99% were off of warfarin at 1 year.*
* PREVAIL trial
• Patients treated with the Watchman therapy had a 71% relative reduction in major bleeding after six months compared to patients treated with warfarin.*
* After per-protocol cessation of anti-thrombotics by WATCHMAN patients. Source: Price MJ. Avoidance of Major Bleeding with WATCHMAN LAA Closure Compared with Long-Term Anticoagulation: A Pooled Analysis of PROTECT AF and PREVAIL trials. TCT 2014.
You may also be interested in
The experts from the Structural and Congenital Heart Center at Hackensack University Medical Center are dedicated to providing you with comprehensive care for the life-long management and treatment of your congenital heart disease and structural heart conditions including aortic stenosis or mitral valve prolapse.